ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role ...
Boston Scientific has announced new data backing its Farapulse pulsed field ablation (PFA) platform for treating AFib.
With Novo Nordisk’s pill version of Wegovy now widely available, GLP-1 drugs are poised for even greater adoption.